| S2 Fluid Pack on the Cobas b 221 system- Catalog Number 03260925184
Blood Gas and Electrolytes Analyzer; The Roche Diagnostics Omni S Analyzer i…Z-2330-2015 · CHL | Roche Diagnostics Operations, Inc. | Recall | Aug 5, 2015FDA classification date |
| Cholesterol CHOD-PAP.
In vitro diagnostic reagent system intended for use on the Hitachi systems for The quantitative determination of total cho…Z-1920-2015 · CHH | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| Cholesterol Gen.2.
The cassette COBAS Integra Cholesterol Gen.2 (CHOL2) contains an in vitro diagnostic reagent system intended for use on COBAS…Z-1921-2015 · CHH | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| Creatinine Plus.
Intended for use on Hitachi/MODULAR systems for the quantitative determination of the creatinine concentration in serum, plasma…Z-1922-2015 · JJE | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| Creatinine Plus ver. 2.
Intended for use on COBAS INTEGRA systems , cobas c111, and cobas c systems for the quantitative determination of the cr…Z-1923-2015 · JFY | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| HDL-Cholesterol gen.3.
For the quantitative determination of high-density lipoprotein Cholesterol (HDL-C) in serum and plasma.Z-1924-2015 · LBS | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| HDL-Cholesterol plus gen.3.; and Small Supersized
Intended for use on COBAS Integra 800 and 400 plus systems, cobas c111, and cobas c systems fo…Z-1925-2015 · LBS | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| Lactate.
Intended for use on COBAS INTEGRA 800 and 400 plus systems, cobas c111, Roche/Hitachi MODULAR systems, and cobas c systems for the quan…Z-1926-2015 · CFJ | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| LDL-Cholesterol gen.2.
The Boehringer Mannheim Direct LDL-Cholesterol test in intended for the quantitative determination of low-density lipopr…Z-1927-2015 · MRR | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| LDL-Cholesterol plus gen.2.
The Boehringer Mannheim Direct LDL-Cholesterol test in intended for the quantitative determination of low-density l…Z-1928-2015 · LBR | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| Triglycerides GPO.
In vitro test for the quantitative determination of triglycerides in human serum and plasma on the COBAS Integra 800 and 400 …Z-1929-2015 · JJE | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| Triglycerides/Glycerol Blanked.
In vitro test for the quantitative determination of triglycerides in human serum and plasma or Roche/Hitachi MOD…Z-1930-2015 · CDT | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| Uric Acid plus ver.2
In vitro test for the quantitative determination of uric acid in human serum, plasma and urine or Roche/Hitachi MODULAR sys…Z-1931-2015 · KNK | Roche Diagnostics Operations, Inc. | Recall | Jun 27, 2015FDA classification date |
| Homocysteine test system - Homocysteine Reagent.
05385415190; Homocysteine 100 Tests, cobas c, COBAS INTEGRA
Homocysteine Enzymatic Assay is an …Z-1622-2015 · LPS | Roche Diagnostics Operations, Inc. | Recall | May 15, 2015FDA classification date |
| Cobas b 221 (versions 5 and 6) Blood Gas and Electrolytes AnalyzerZ-1041-2015 · CGA | Roche Diagnostics Operations, Inc. | Recall | Feb 2, 2015FDA classification date |
| ACCU-CHEK Tender I 13/60 10 pieces
Product Usage: Usage:
Intended for the infusion and/or injection of fluids into the body below the surface o…Z-0883-2015 · FPA | Roche Diagnostics Operations, Inc. | Recall | Dec 30, 2014FDA classification date |
| ACCU-CHEK Tender I 13/80 10 pieces
Product Usage:
Intended for the infusion and/or injection of fluids into the body below the surface of the sk…Z-0884-2015 · FPA | Roche Diagnostics Operations, Inc. | Recall | Dec 30, 2014FDA classification date |
| ACCU-CHEK Tender I 13/110 10 pieces
Product Usage:
Intended for the infusion and/or injection of fluids into the body below the surface of the s…Z-0885-2015 · FPA | Roche Diagnostics Operations, Inc. | Recall | Dec 30, 2014FDA classification date |
| ACCU-CHEK Tender I 17/60 10 pieces
Product Usage:
Intended for the infusion and/or injection of fluids into the body below the surface of the sk…Z-0886-2015 · FPA | Roche Diagnostics Operations, Inc. | Recall | Dec 30, 2014FDA classification date |
| ACCU-CHEK Tender I 17/80 10 pieces
Product Usage:
Intended for the infusion and/or injection of fluids into the body below the surface of the sk…Z-0887-2015 · FPA | Roche Diagnostics Operations, Inc. | Recall | Dec 30, 2014FDA classification date |
| ACCU-CHEK Tender I 17/110 10 pieces
Product Usage:
Intended for the infusion and/or injection of fluids into the body below the surface of the s…Z-0888-2015 · FPA | Roche Diagnostics Operations, Inc. | Recall | Dec 30, 2014FDA classification date |
| ACCU-CHEK Tender II 13/60 10 + 10 pieces
Product Usage:
Intended for the infusion and/or injection of fluids into the body below the surface of …Z-0889-2015 · FPA | Roche Diagnostics Operations, Inc. | Recall | Dec 30, 2014FDA classification date |
| ACCU-CHEK Tender II 13/80 10 + 10 pieces
Product Usage:
Intended for the infusion and/or injection of fluids into the body below the surface of …Z-0890-2015 · FPA | Roche Diagnostics Operations, Inc. | Recall | Dec 30, 2014FDA classification date |
| ACCU-CHEK Tender II 13/110 10 + 10 pieces
Product Usage:
Intended for the infusion and/or injection of fluids into the body below the surface of…Z-0891-2015 · FPA | Roche Diagnostics Operations, Inc. | Recall | Dec 30, 2014FDA classification date |
| ACCU-CHEK Tender II 17/60 10 + 10 pieces
Product Usage:
Intended for the infusion and/or injection of fluids into the body below the surface of …Z-0892-2015 · FPA | Roche Diagnostics Operations, Inc. | Recall | Dec 30, 2014FDA classification date |